Xanator | Annual Sales Report | Pharmacompass.com

Germany

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bayer

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 466

2019 Revenue in Millions : 524

Growth (%) : -11

Portfolio PDF

Product Web Link

Corporate PDF

02 Brand Name : Gadovist product family

Germany

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bayer

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 460

2020 Revenue in Millions : 466

Growth (%) : 9

Portfolio PDF

Product Web Link

Corporate PDF

03 Brand Name : ZetiaTM

Germany

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bayer

Main Therapeutic Indication : Cardiovascular

Currency : USD

2014 Revenue in Millions : -2.30%

2013 Revenue in Millions :

Growth (%) :

Portfolio PDF

Product Web Link

Corporate PDF

04 Brand Name : Gadavist/Gadovist

Germany

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bayer

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 453

2016 Revenue in Millions : 429

Growth (%) : 5

Portfolio PDF

Product Web Link

Corporate PDF

05 Brand Name : Gadavist/Gadovist

Germany

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bayer

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 414

2017 Revenue in Millions : 412

Growth (%) : 0%

Portfolio PDF

Product Web Link

Corporate PDF

06 Brand Name : Gadavist/Gadovist

Germany

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bayer

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 367

2015 Revenue in Millions : 307

Growth (%) : 19

Portfolio PDF

Product Web Link

Corporate PDF

07 Brand Name : Gadavist/Gadovist

Germany

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bayer

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 436

2018 Revenue in Millions : 399

Growth (%) : 9

Portfolio PDF

Product Web Link